|
|
Blood, 1 June 2004, Vol. 103, No. 11, pp. 4344-4352.
Prepublished online as a Blood First Edition Paper on February 19, 2004; DOI 10.1182/blood-2003-07-2534.
Previous Article | Table of Contents | Next Article 
TRANSPLANTATION
Hematopoietic stem cell dose correlates with the speed of immune reconstitution after stem cell transplantation
Benny J. Chen,
Xiuyu Cui,
Gregory D. Sempowski,
Jos Domen, and
Nelson J. Chao
From the Bone Marrow Transplantation Program, Departments of Medicine and Immunology, Human Vaccine Institute, Duke University Medical Center, Durham, NC.
In the current study, we tested whether higher numbers of hematopoietic stem cells correlate with the speed of immune reconstitution in a congenic transplantation model (C57BL/Ka, CD45.1, Thy1.1 C57BL/6, CD45.2, Thy1.2) using purified hematopoietic stem cells (c-Kit+Thy1.1lowLin-/lowSca-1+). There were 3 different doses of stem cells used (400, 1000, and 5000). Phenotypic analyses in peripheral blood and spleen demonstrated that higher numbers of infused stem cells are associated with more rapid regeneration of T cells (CD4+, CD8+, naive CD4+, naive CD8+) and B cells at early time points. The numbers of T and B cells eventually became equivalent between different dose groups at late time points. Production of interleukin-2 and inter-feron- per T cell was similar regardless of stem cell dose even when tested at the time when there were significant differences in peripheral T-cell counts. The improved immune recovery was attributed to a more rapid regeneration of donor-type immune cells. Higher numbers of total thymocytes and signal joint T-cell receptor excision circles were observed in the higher dose stem cell recipients, suggesting that accelerated regeneration of T cells was due to enhanced thymopoiesis. (Blood. 2004;103:4344-4352)

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Mariotti, J. Foley, U. Jung, T. Borenstein, N. Kantardzic, S. Han, J. T. Hanson, E. Wong, N. Buxhoeveden, J. B. Trepel, et al.
Ex Vivo Rapamycin Generates Apoptosis-Resistant Donor Th2 Cells That Persist In Vivo and Prevent Hemopoietic Stem Cell Graft Rejection
J. Immunol.,
January 1, 2008;
180(1):
89 - 105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Dallas, B. Varnum-Finney, P. J. Martin, and I. D. Bernstein
Enhanced T-cell reconstitution by hematopoietic progenitors expanded ex vivo using the Notch ligand Delta1
Blood,
April 15, 2007;
109(8):
3579 - 3587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Chen, D. Deoliveira, X. Cui, N. T. Le, J. Son, J. F. Whitesides, and N. J. Chao
Inability of memory T cells to induce graft-versus-host disease is a result of an abortive alloresponse
Blood,
April 1, 2007;
109(7):
3115 - 3123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Chao, S. G. Emerson, and K. I. Weinberg
Stem Cell Transplantation (Cord Blood Transplants)
Hematology,
January 1, 2004;
2004(1):
354 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|